It was confirmed that purinergic antiplatelet agents can be involved in cancer metastasis by inducing the expression of MMP1, which is involved in cell motility, by increasing the secretion of SERPINE1 in cancer cells while decreasing cancer cell proliferation. Here, MMP1 is linked to cancer.